Live Chat
Select Page
Yashoda Hospitals > Doctors > Hematology & BMT > Dr. K Ashok Kumar
Dr. K Ashok Kumar

Dr. K Ashok Kumar

MBBS, DNB(NIMS), DM (NIMS) PDF (BMT) (CMC-Vellore)

Department : Hematology & BMT, Pediatric Oncology
Exp: 18 yrs
Designation: Sr. Consultant Hemato- oncology and BMT Physician
Languages: Telugu, Tamil, Hindi, English
Med Reg No: 52687

Day time OPD:
MON - SAT : 09:00 AM - 05:00 PM

Location: Somajiguda
Book An Appointment Book Online Consultation
Download Profile

About the Doctor

Dr Karanam Ashok Kumar is one of the leading hemato-oncologists in Hyderabad. He is currently working as a Consultant Hematologist & BMT specialist at Yashoda Hospitals, Somajiguda, Hyderabad.

Dr Ashok Kumar is recognised as one of the most experienced Bone Marrow Transplant (BMT) physicians in the region. His clinical expertise encompasses the treatment of complex hematological disorders including Leukemia, Myelodysplastic Syndromes, Lymphomas, Multiple Myeloma, Amyloidosis, Bone Marrow/Stem Cell Transplantation, Thalassemia, Sickle Cell Anemia, and Aplastic Anemia. He has successfully performed over 400 transplants in both adult and paediatric patients.

Educational Qualifications

  • 2005: MBBS, S.V. Medical College, Tirupati.
  • 2009 to 2012: DNB, Nizam's Institute of Medical Sciences, Hyderabad.
  • 2013 to 2016: DM, Nizam's Institute of Medical Sciences, Hyderabad.
  • 2018 to 2019: Post-Doctoral Fellowship, Christian Medical College, Vellore.

Experience

  • 2016 to 2018: Assistant Professor, Nizam's Institute of Medical Sciences.
  • August 2019 to March 2020: Consultant Haemato-Oncologist & BMT Specialist, Care Hospitals.
  • 2020 to 2025: Consultant Haemato-Oncologist & BMT Specialist.
  • 2021: Associate Professor, Mehdi Nawaj Jung Regional Cancer Center.
  • July 2025 to Present: Senior Consultant Haemato-Oncologist & BMT Specialist, Yashoda Hospitals, Somajiguda.

Services offered

  • Hematology (Adult & Pediatric)
  • Diagnosis and management of anemia and complex blood disorders in children and adults
  • Evaluation and treatment of bleeding and clotting disorders, including hemophilia and platelet disorders
  • Management of thalassemia and other inherited hematological conditions
  • Treatment of aplastic anemia
  • Evaluation of abnormal blood counts, lymphadenopathy, and bone marrow disorders
  • Management of myelodysplastic syndromes (MDS) and other hematological abnormalities
  • Haemato-oncology:
  • Diagnosis and treatment of acute and chronic leukemias in pediatric and adult patients
  • Management of Hodgkin and Non-Hodgkin lymphomas
  • Treatment of multiple myeloma and plasma cell disorders
  • Comprehensive care for pediatric blood cancers and hematological malignancies
  • Multidisciplinary cancer care with personalized treatment planning
  • Bone Marrow Transplant (BMT)
  • Autologous stem cell transplantation for selected hematological malignancies
  • Allogeneic bone marrow transplantation using matched donors
  • Haploidentical (half-matched donor) transplants
  • Pre-transplant evaluation for both pediatric and adult recipients and donors
  • Stem cell harvesting and transplant coordination
  • Post-transplant monitoring and long-term follow-up care
  • Management of transplant complications, including graft-versus-host disease (GVHD)

Special Interest and Expertise

  • Leukemia
  • Myelodysplastic Syndromes
  • Lymphomas
  • Multiple Myeloma
  • Amyloidosis
  • Thalassemia
  • Sickle Cell Anemia
  • Aplastic Anemia.
  • Bone Marrow DisordersBone Marrow Disorders
  • Stem Cell Transplant (Autologous & Allogeneic)
Download Profile
  • Indian Society of Blood and Marrow Transplantation
  • Asia Pacific Society of Blood and Marrow Transplantation
  • Management of Hemato-Oncology Children During COVID-19 Crisis
    Ranjit Kumar C.S., Raghu K. Sukumaran, Anil Aribandi, Ashok Kumar K., Arun Kumar Lingutla, Krishnamani K.V. International Journal of Research in Pharmaceutical Sciences. Vol. 11, SPL 1 (2020).
  • Managing Metastatic Renal Cell Carcinoma: Challenges, Pitfalls, and Outcomes in the Real World
    Kumar K.A., Sadashivudu G., Krishnamani K.V., Linga V.G., Maddali L.S., Digumarti R.R. Indian Journal of Medical and Paediatric Oncology. 2016;37:260–264.
  • Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: 8 Years’ Experience from a Tertiary Care Center in India
    Danthala M., Gundeti S., Maddali L.S., Pillai A., Puligundla K.C., Adusumilli R.P. South Asian Journal of Cancer. 2016;5:176–178.
  • Thiopurine Methyltransferase Polymorphisms in Children with Acute Lymphoblastic Leukemia
    Linga V.G., Patchva D.B., Mallavarapu K.M., Tulasi V., Kalpathi K.I., Pillai A., Gundeti S., Rajappa S.J., Digumarti R. Indian Journal of Medical and Paediatric Oncology. 2014;35(4):Oct–Dec.
  • Fanconi Syndrome Following Honeybee Stings – A Case Report
    Rapur Ram, Gudithi Swarnalatha, Karanam Ashok Kumar, Hasaagrahara Radhakrishna Madhuri, Kaligotla Venkata Dakshinamurthy International Urology and Nephrology. 2012;44:315–318.
  • Generic Imatinib in Chronic Myeloid Leukemia: Survival of the Cheapest
    Danthala M., Gundeti S., Kuruva S.P., Puligundla K.C., Adusumilli P., Karnam A.P., Bala S., Konatam M.L., Maddali L.S., Digumarti R.R. Clinical Lymphoma, Myeloma & Leukemia. 2017 May 10.
  • The Role of Mutation Testing in Patients with CML-CP After Imatinib Failure and Their Outcomes After Treatment Modification: A Single Institutional Experience Over 13 Years
    Chaitanya P.K., Kumar K.A., Stalin B., Sadashivudu G., Srinivas M.L. Indian Journal of Medical and Paediatric Oncology. 2017;38:328–333.
  • Clinicopathological Features and Outcomes in Primary Central Nervous System Lymphoma: A 10-Year Experience
    Puligundla C.K., Bala S., Karnam A.K., Gundeti S., Paul T.R., Uppin M.S., et al. Indian Journal of Medical and Paediatric Oncology. 2017;38:478–482.
  • Impact of Cytogenetics on Outcomes in Pediatric Acute Lymphoblastic Leukemia
    Chennamaneni R., Gundeti S., Konatam M.L., Bala S., Kumar A., Maddali L.S. South Asian Journal of Cancer. 2018 Oct–Dec;7(4):263–266.
  • Clinicopathological Features, Treatment and Survival Outcomes of Synovial Sarcoma
    Kuruva S.P., Bala S., Konatam M.L., Karnam A.K., Maddali L.S., Gundeti S. South Asian Journal of Cancer. 2018 Oct–Dec;7(4):270–272.
  • Pattern of Metastases and Their Impact on Outcomes in Stage IV Non-Small Cell Lung Cancer: An Institutional Experience from South India
    Stalin B., Gundeti S., Kumar A., Maddali L.S., Kandula R., Digumarti R. Medical Oncology, Nizam’s Institute of Medical Sciences, Hyderabad & Homi Bhabha Cancer Hospital and Research Center, Visakhapatnam.

Posters/Papers/Oral Presentations

  • International Conferences

  • Impact of COVID-19 and Lockdown on Adherence to Treatment Schedule Among Cancer Patients
    K. Kalpathi, D. Darshini, A. Aribandi, A.K. Pillai, R. Kumar, A.K. Lingutla, M. Krishnamani, K. Mathi Presented at ESMO Asia Virtual Congress, Singapore, Nov 2020.
  • Challenges Faced by Cancer Patients During the COVID-19 Pandemic
    M. Krishnamani, R. Kishore, P. Gundlapally, A.K. Pillai, R. Kumar, A.K. Lingutla, A. Aribandi, K. Mathi Presented at ESMO Asia Virtual Congress, Singapore, Nov 2020.
  • Mutation Analysis and Treatment Outcomes of BCR-ABL Tyrosine Kinase Domains in CML Patients with Imatinib Treatment Failure
    Poster Presentation, ASH Annual Meeting, 2016.
  • Impact of Imatinib on Linear Growth and Body Mass Index in Children with Chronic Myeloid Leukemia
    Poster Presentation, SIOP (International Society of Paediatric Oncology), 2016.

  • National Conferences

  • Romiplostim in the Treatment of Primary Immune Thrombocytopenia – An Observational Study
    Ranjit K. C.S., Ashok K. K., Rajkishore P., Rajesh M. Gottipati, Anil Aribandi Haematocon, Nov 2020.
  • Use of Monoclonal Antibodies for Hematologic Conditions During COVID-19
    Anil Aribandi, Krishnamani K.V., Ranjith Kumar C.S., Arun Lingutla, Ashok Kumar K., Raj Kishore P., Pravallika M.R.P.L. Haematocon, Nov 2020.
  • Incidence of COVID-19 Infection in Haemato-Oncology Unit in a Non-COVID Hospital
    Ranjit K. C.S., Rajesh M. Gottipati, Krishnamani K.V., Ashok K. K., Arun Kumar Lingutla, Anil Aribandi Haematocon, Nov 2020.
  • Decitabine in Elderly AML – The Road Less Travelled
    Platform Presentation, Haematocon, 2014.
  • Clinical Profile of RCC – Results from a Tertiary Care Centre
    Poster Presentation, SAARC Oncology Conference, 2014.
  • Clinical Profile of RCC – Results from a Tertiary Care Centre
    Poster Presentation, SAARC Oncology Conference, 2014.
  • First Case of Allogeneic Stem Cell Transplant in a Low-Resource Setting for Aplastic Anemia
    Presented at IACMCON, 2010.

  • Early Career Presentations

  • A Case Report of Hepatic Amyloidosis
    Platform Presentation, GECON, 2009.
  • A Patient Presenting with Polyuria and Polydipsia
    Poster Presentation, APICON, 2010.
  • A Case Report of Cryptococcal Septicemia in an HIV Patient
    Poster Presentation, ASICON, 2010.
  • Performance of APACHE II in Estimating Mortality Risk in Critically Ill Patients with Infections Admitted to Acute Medical Care
    Platform Presentation, APICON, 2011.

Blogs by Dr. K Ashok Kumar

spherocytosis_main
స్పిరోసైటోసిస్ : కారణాలు, లక్షణాలు, చికిత్స

Doctor Talks

No videos found.

Health Talks

BMT Decoded: Myths, Facts & Life-Changing Science

Minutes with Medic

10 లక్షల్లో ఒకరికి వచ్చే కంజెనిటల్ అమెగాకార్యోసైటిక్ థ్రోంబోసైటోపెనియా- డా. అశోక్ కుమార్
బ్లడ్ క్యాన్సర్ మీ ఇంట్లో పెద్దవాళ్లకు ఉంటే.. మీకు వస్తుందా? – డా. అశోక్ కుమార్
రక్త క్యాన్సర్‌కి పరిష్కారం ఉందా? – డా. అశోక్ కుమార్

FAQ's

    Dr.Ashok Kumar holds the following qualifications: MBBS, DNB(NIMS), DM (NIMS) PDF (BMT) (CMC-Vellore)

    Dr.Ashok Kumar is a Senior Consultant (Hemato-oncology) and BMT Physician specialised in the treatment of various cancerous and noncancerous blood related conditions.

    Dr.Ashok Kumar practices at Yashoda Hospitals, Somajiguda.

    You can schedule an appointment with Dr.Ashok Kumar for both an Online Video Consultation and an OPD Consultation by visiting his profile on Yashoda Hospitals.





      •

      Book an appointment
      in 2 minutes